CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.

CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.

CXC ligand 17 (CXCL17) is a novel CXC chemokine whose clinical significance remains largely unknown. In the present study, we characterized the prognostic value of CXCL17 in patients with hepatocellular carcinoma (HCC) and evaluated the association of CXCL17 with immune infiltration. We examined CXC...

Full description

Bibliographic Details
Main Authors: Li Li, Jing Yan, Jing Xu, Chao-Qun Liu, Zuo-Jun Zhen, Huan-Wei Chen, Yong Ji, Zhi-Peng Wu, Jian-Yuan Hu, Limin Zheng, Wan Yee Lau
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4193880?pdf=render

Internet

http://europepmc.org/articles/PMC4193880?pdf=render

Similar Items